Cyclacel Pharmaceuticals, Inc. (CYCC) DCF Valuation

Cyclacel Pharmaceuticals, Inc. (CYCC) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

Cyclacel Pharmaceuticals, Inc. (CYCC) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Simplify Cyclacel Pharmaceuticals, Inc. (CYCC) valuation with this customizable DCF Calculator! Featuring real Cyclacel Pharmaceuticals, Inc. (CYCC) financials and adjustable forecast inputs, you can test various scenarios and discover Cyclacel Pharmaceuticals, Inc. (CYCC) fair value in just minutes.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .4 .4 .4 .4 .4 .4
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -9.7 -10.6 -22.7 -27.6 -25.4 .3 .3 .3 .3 .3
EBITDA, % 100 100 100 100 -6052.86 60 60 60 60 60
Depreciation .0 .0 .0 .0 .0 .3 .3 .3 .3 .3
Depreciation, % 100 100 100 100 7.38 81.48 81.48 81.48 81.48 81.48
EBIT -9.7 -10.6 -22.7 -27.7 -25.5 .3 .3 .3 .3 .3
EBIT, % 100 100 100 100 -6060.24 60 60 60 60 60
Total Cash 11.9 33.4 36.6 18.3 3.4 .4 .4 .4 .4 .4
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 1.3 1.3 .0 .0 .0
Account Receivables, % 100 100 100 100 0
Inventories .7 .7 .6 -5.6 .0 .3 .3 .3 .3 .3
Inventories, % 100 100 100 100 0 80 80 80 80 80
Accounts Payable .9 .5 2.1 2.6 3.5 .4 .4 .4 .4 .4
Accounts Payable, % 100 100 100 100 843.57 100 100 100 100 100
Capital Expenditure .0 -.1 .0 .0 .0 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 -1.43 -0.28571 -0.28571 -0.28571 -0.28571 -0.28571
Tax Rate, % 11.73 11.73 11.73 11.73 11.73 11.73 11.73 11.73 11.73 11.73
EBITAT -8.3 -9.3 -18.9 -22.6 -22.5 .2 .2 .2 .2 .2
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -9.4 -9.7 -15.8 -15.9 -27.1 -3.2 .6 .6 .6 .6
WACC, % 6.72 6.73 6.71 6.7 6.73 6.72 6.72 6.72 6.72 6.72
PV UFCF
SUM PV UFCF -1.3
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 1
Terminal Value 12
Present Terminal Value 9
Enterprise Value 7
Net Debt -3
Equity Value 11
Diluted Shares Outstanding, MM 1
Equity Value Per Share 12.64

What You Will Get

  • Editable Forecast Inputs: Easily modify assumptions (growth %, margins, WACC) to explore various scenarios.
  • Real-World Data: Cyclacel Pharmaceuticals’ financial data pre-filled to kickstart your analysis.
  • Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value for you.
  • Customizable and Professional: A refined Excel model that adjusts to your valuation requirements.
  • Built for Analysts and Investors: Perfect for evaluating projections, confirming strategies, and saving time.

Key Features

  • Comprehensive DCF Analysis Tool: Offers detailed unlevered and levered DCF valuation models tailored for Cyclacel Pharmaceuticals, Inc. (CYCC).
  • WACC Calculation Module: Features a pre-built Weighted Average Cost of Capital sheet with adjustable parameters.
  • Customizable Forecast Inputs: Adapt growth projections, capital expenditures, and discount rates as needed.
  • Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios specific to Cyclacel Pharmaceuticals, Inc. (CYCC).
  • Interactive Dashboard and Visualizations: Graphical representations summarize essential valuation metrics for straightforward analysis.

How It Works

  • Download: Obtain the pre-configured Excel file featuring Cyclacel Pharmaceuticals, Inc.'s (CYCC) financial data.
  • Customize: Modify projections, such as revenue growth, EBITDA %, and WACC.
  • Update Automatically: The intrinsic value and NPV calculations refresh in real-time.
  • Test Scenarios: Develop various projections and instantly compare results.
  • Make Decisions: Utilize the valuation findings to inform your investment strategy.

Why Choose This Calculator for Cyclacel Pharmaceuticals, Inc. (CYCC)?

  • All-in-One Solution: Combines DCF, WACC, and financial ratio analyses tailored for Cyclacel Pharmaceuticals.
  • Flexible Inputs: Modify the yellow-highlighted cells to explore different financial scenarios for (CYCC).
  • In-Depth Analysis: Automatically computes Cyclacel's intrinsic value and Net Present Value.
  • Preloaded Information: Historical and projected data provide reliable starting points for analysis.
  • Expert-Level Tool: Perfect for financial analysts, investors, and consultants focusing on (CYCC).

Who Should Use This Product?

  • Investors: Accurately assess Cyclacel Pharmaceuticals’ (CYCC) fair value prior to making investment choices.
  • CFOs: Utilize a professional-grade DCF model for financial reporting and analysis specific to Cyclacel Pharmaceuticals.
  • Consultants: Efficiently customize the template for valuation reports tailored to Cyclacel Pharmaceuticals’ clients.
  • Entrepreneurs: Acquire knowledge on financial modeling techniques employed by top-tier pharmaceutical companies.
  • Educators: Implement it as a teaching resource to illustrate valuation methodologies in the pharmaceutical sector.

What the Template Contains

  • Comprehensive DCF Model: Editable template featuring in-depth valuation calculations.
  • Real-World Data: Cyclacel Pharmaceuticals' (CYCC) historical and projected financials preloaded for analysis.
  • Customizable Parameters: Modify WACC, growth rates, and tax assumptions to explore various scenarios.
  • Financial Statements: Complete annual and quarterly breakdowns for enhanced insights.
  • Key Ratios: Integrated analysis for profitability, efficiency, and leverage metrics.
  • Dashboard with Visual Outputs: Charts and tables designed for clear, actionable results.

No products were found matching.